Why the study?
Does long-term anticoagulant therapy reduce embolic episodes in patients with rheumatic heart disease, mitral valve disease, and fibrillation?
Does long-term anticoagulant therapy reduce embolic episodes in patients with rheumatic heart disease, mitral valve disease, and fibrillation?
Long-term anticoagulant therapy markedly reduces the incidence of recurrent embolic episodes in patients with rheumatic mitral valve disease and fibrillation.
Answers are grounded in this paper and cite their sources.
Supports anticoagulation for fewer emboli in rheumatic mitral AF; leaves open need for randomized confirmation.
Long-Term Anticoagulant TherapyRheumatic Heart DiseaseThere are only a few studies on the protective effect of long-term anticoagulant therapy in rheumatic heart disease, but from the data recorded this may be a major therapeutic indication for such therapy. In Owren's study17 a group of 17 patients with disease of the mitral valve, fibrillation and recurrent embolic incidents before therapy experienced only 3 or 4 embolic episodes in a total treatment period of ninety-four years. In a corresponding observation period for each patient before the start of therapy, a total of 35 major embolic episodes had been recorded. In another . . .
No takes yet. Share an insight, caveat, or question.
P. A. Owren (1963) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: